• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Device magnetic cell selection system for cd34+ cells from hpc-apheresis used in treatment of acute myeloid leukemia (aml)
Definition For processing hematopoietic progenitor cells-apheresis (HPC-A) from an HLA-identical donor to obtain a CD34 positive cell enriched population that will provide for hematopoietic reconstitution following a myeloablative preparative regimen without the need for additional graft-vs-host disease (GVHD) prophylaxis.
Product CodeOVG
Device Class Humanitarian Device Exemption

Device Problems
Device Issue 32
No Information 4
Device maintenance issue 3
No Known Device Problem 2
Device Difficult to maintain 1
Disassembly 1
No code available 1
Improper or incorrect procedure or method 1
Mechanical issue 1
Detachment of device or device component 1
Loose or intermittent connection 1
Material rupture 1
Total Device Problems 49

-
-